Market revenue in 2024 | USD 90.9 million |
Market revenue in 2030 | USD 178.2 million |
Growth rate | 11.9% (CAGR from 2025 to 2030) |
Largest segment | Exocrine |
Fastest growing segment | Endocrine |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Exocrine, Endocrine |
Key market players worldwide | Accuray Inc, AstraZeneca PLC ADR, Novartis AG ADR, Pfizer Inc., F. Hoffmann-La Roche Ltd., Bristol-Myers Squibb Company, Ipsen Pharma, Eli Lilly and Co, Siemens Healthineers AG ADR, Elekta AB ADR |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pancreatic cancer treatment market will help companies and investors design strategic landscapes.
Exocrine was the largest segment with a revenue share of 88.34% in 2024. Horizon Databook has segmented the France pancreatic cancer treatment market based on exocrine, endocrine covering the revenue growth of each sub-segment from 2018 to 2030.
The pancreatic cancer treatment market in France is evolving as the country faces a rising incidence of the disease. According to WHO, in 2022, France recorded 15,895 new cases of pancreatic cancer, pancreatic cancer remains one of the leading causes of cancer-related deaths in France.
The French healthcare system is well-equipped to support the growing demand for treatment, with a strong presence of major pharmaceutical companies such as AstraZeneca, Novartis AG, and Bristol-Myers Squibb Company, who dominate the market with established therapies such as gemcitabine and nabpaclitaxel.
Chemotherapy continues to be the cornerstone of treatment in France, though the market is increasingly seeing a shift towards more advanced therapies, including targeted therapies and immunotherapies.
Horizon Databook provides a detailed overview of country-level data and insights on the France pancreatic cancer treatment market , including forecasts for subscribers. This country databook contains high-level insights into France pancreatic cancer treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account